| __timestamp | Corcept Therapeutics Incorporated | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 18372000 | 382096000000 |
| Thursday, January 1, 2015 | 15419000 | 345927000000 |
| Friday, January 1, 2016 | 23844000 | 312303000000 |
| Sunday, January 1, 2017 | 40376000 | 325441000000 |
| Monday, January 1, 2018 | 75247000 | 368298000000 |
| Tuesday, January 1, 2019 | 89017000 | 492381000000 |
| Wednesday, January 1, 2020 | 114764000 | 455833000000 |
| Friday, January 1, 2021 | 113864000 | 526087000000 |
| Saturday, January 1, 2022 | 130991000 | 633325000000 |
| Sunday, January 1, 2023 | 184353000 | 729924000000 |
| Monday, January 1, 2024 | 729924000000 |
Unleashing insights
In the ever-evolving world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Takeda Pharmaceutical Company Limited and Corcept Therapeutics Incorporated have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Takeda's R&D expenses have consistently dwarfed those of Corcept, with Takeda's spending peaking at approximately 730 billion yen in 2023, a staggering 4,000 times more than Corcept's highest expenditure in the same period. This significant difference highlights Takeda's robust focus on innovation, likely driven by its expansive global operations and diverse product pipeline.
Corcept, on the other hand, has shown a steady increase in R&D spending, growing by over 900% from 2014 to 2023. This growth reflects Corcept's strategic focus on niche markets and targeted therapies, underscoring its commitment to innovation within its specialized field.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and argenx SE
R&D Insights: How Takeda Pharmaceutical Company Limited and Dr. Reddy's Laboratories Limited Allocate Funds
Research and Development Investment: Takeda Pharmaceutical Company Limited vs Axsome Therapeutics, Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Pharming Group N.V.
Takeda Pharmaceutical Company Limited vs Corcept Therapeutics Incorporated: A Gross Profit Performance Breakdown
Comparing Innovation Spending: Takeda Pharmaceutical Company Limited and Geron Corporation
R&D Insights: How Takeda Pharmaceutical Company Limited and Mesoblast Limited Allocate Funds
BeiGene, Ltd. vs Corcept Therapeutics Incorporated: Strategic Focus on R&D Spending
R&D Insights: How Corcept Therapeutics Incorporated and Viking Therapeutics, Inc. Allocate Funds
R&D Insights: How Corcept Therapeutics Incorporated and Mesoblast Limited Allocate Funds
Research and Development Investment: Corcept Therapeutics Incorporated vs Geron Corporation
R&D Insights: How Corcept Therapeutics Incorporated and Wave Life Sciences Ltd. Allocate Funds